相关实验视频
Updated: Jan 10, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.8K
MAPK13促进了乳头甲状腺癌的进展
Runyu Zhao1,2, Ziqi Su3,4, Zhihan Wan5
1Department of Otorhinolaryngology Head and Neck Surgery, Gongli Hospital of Shanghai Pudong New Area, Shanghai, China.
European thyroid journal
|November 20, 2025
概括
甲基因激活蛋白激酶13 (MAPK13) 通过增强细胞增殖和迁移,促进乳头甲状腺癌 (PTC) 的进展. MAPK13是PTC治疗的潜在治疗生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的甲状腺恶性瘤类型.
- 识别驱动PTC进展的基因对于开发有效治疗方法至关重要.
研究的目的:
- 分析影响PTC进展的基因.
- 研究MAPK13在PTC发育和攻击性中的特定作用.
主要方法:
- 使用GEO数据集对PTC与正常甲状腺组织的基因表达差异分析.
- 在TCGA数据上进行考克斯回归和LASSO分析,以确定关键基因.
- 功能测试 (CCK-8,EDU,伤口愈合,穿孔,流细胞计) 和异种移植模型来评估MAPK13的功能.
- 基因组丰富分析 (GSEA) 探索潜在的分子途径.
主要成果:
- MAPK13被确定为促进PTC进展的关键基因.
- 高MAPK13表达与晚期瘤阶段,转移和较差的存活率相关.
- 过度表达MAPK13增强了PTC细胞的增殖,迁移和入侵,同时抑制了细胞亡.
- 抑制MAPK13可以逆转这些效应,并抑制瘤生长.
- MAPK13与表皮层-介质细胞过渡 (EMT) 标记物有关.
结论:
- MAPK13显著促进PTC细胞的恶性行为,包括EMT.
- MAPK13代表了皮肤状甲状腺癌的潜在诊断和治疗生物标志物.
相关概念视频
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K

